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Abstract
Objective: Genistein is a soy isoflavone that has antitumor activity both in vitro and in vivo. It has been shown that
genistein inhibits many type of cancers including prostate cancer (PCa) by regulating several cell signaling pathways and
microRNAs (miRNAs). Recent studies suggest that the long non-coding RNAs (lncRNAs) are also involved in many cellular
processes. At present there are no reports about the relationship between gensitein, miRNAs and lncRNAs. In this study, we
focused on miRNAs, lncRNA that are regulated by genistein and investigated their functional role in PCa.
Method: Microarray (SurePrint G3 Human GE 8660K) was used for expression profiling of genistein treated and control PCa
cells (PC3 and DU145). Functional assay (cell proliferation, migration, invasion, apoptosis and cell cycle assays) were
performed with the PCa cell lines, PC3 and DU145. Both in vitro and in vivo (nude mouse) models were used for growth
assays. Luciferase reporter assays were used for binding of miR-34a to HOTAIR.
Results: LncRNA profiling showed that HOTAIR was highly regulated by genistein and its expression was higher in
castration-resistant PCa cell lines than in normal prostate cells. Knockdown (siRNA) of HOTAIR decreased PCa cell
proliferation, migration and invasion and induced apoptosis and cell cycle arrest. miR-34a was also up-regulated by
genistein and may directly target HOTAIR in both PC3 and DU145 PCa cells.
Conclusions: Our results indicated that genistein inhibited PCa cell growth through down-regulation of oncogenic HOTAIR
that is also targeted by tumor suppressor miR-34a. These findings enhance understanding of how genistein regulates
lncRNA HOTAIR and miR-34a in PCa.
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Introduction
Genistein is a dietary soy isoflavone. Its structure is similar to
that of human 17-b-estradiol causing estrogenic and/or antiestro-
genic effects [1]. Genistein is also a protein tyrosine kinase
inhibitor [2] and has antitumor effects in vitro and in vivo. It has
been shown that genistein inhibits many type of cancers including
prostate cancer (PCa) [3,4] through regulation of several cell
signaling pathways such as the Wnt, Akt and JAK/STAT
pathways [5–8].
Recent evidence suggests that non-coding RNAs (ncRNAs) are
involved in many cellular processes. microRNAs (miRNAs), class
of small ncRNAs about 22 nucleotides in length, function as
negative regulators of target mRNAs transcriptionally and post-
transcriptionally [9]. It is known that miRNAs regulate up to two-
thirds of the human genome [10] and play important roles in
numerous biological processes including development, differenti-
ation, proliferation, angiogenesis, metabolism and pluripotency
[11,12]. It has been reported that genistein increased expression of
tumor suppressor miR-146a, causing inhibition of the EGFR and
NF-kB pathway [13,14]. miR-27a has been reported to be a
oncogenic miRNA regulated by genistein and regulates VEGF
signaling by targeting ZBTB10 [15,16]. Our previous studies
showed that genistein treatment significantly down-regulated the
expression of oncogenic miR-151 which directly targets SOX17
and ARHGDIA [17]. SOX17 was reported to be a tumor
suppressor gene that inhibits WNT/b-catenin signaling by
targeting both b-catenin and T-cell factor (TCF)/lymphoid
enhancer factor (LEF) proteins [18–20]. ARHGDIA negatively
regulates the Rho family of GTPases (Rho, Rac, and Cdc42) [21]
that are involved in the WNT signaling pathway [22]. We also
found that genistein down-regulates the RAC1 and EP300 genes
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that are important regulators of VEGF-mediated angiogenesis
[23,24] and the EGFR gene by up-regulating miR-574-3p [25].
NcRNAs are divided into two major classes based on transcript
size; small ncRNAs and long ncRNAs (lncRNAs). lncRNAs are in
general defined as RNA genes larger than 200 nucleotides that
have no protein coding potential. Large scale sequencing of cDNA
libraries and next generation sequencing indicate that lncRNAs in
mammals number in the tens of thousands. So far, only 126
human lncRNAs have been functionally annotated in lncRNA
data base [26]. Thus there are no reports about the relationship
between gensitein and lncRNAs.
The HOX transcript antisense RNA (HOTAIR) gene is located
within the Homeobox C (HOXC) gene cluster on chromosome 12
and encodes s 2.2 kb lncRNA molecule. This gene is shuttled from
chromosome 12 to chromosome 2 by a component of the
Polycomb Repressive Complex 2 (PRC2) and represses transcrip-
tion of homeobox D (HOXD) genes [27]. HOTAIR interacts with
both PRC2 and lysine specific demethylase 1 (LSD1) complexes
and couples histone H3 lysine 27 methylation and lysine 4
demethylation for epigenetic silencing of not only HOXD genes
but also many other genes [28]. This gene is highly expressed in
several cancers such as breast, colorectal, liver, pancreas, and
laryngeal cancer [29–33]. High expression of HOTAIR in breast
cancer is a predictor of metastasis and poor outcome [29].
HOTAIR is also thought to be a potential biomarker for the
existence of lymph node metastasis in hepatocellular carcinoma
[34]. HOTAIR is a negative prognostic factor and acts as an
oncogene in pancreatic cancer both in vitro and in vivo [32].
Therefore in this study, we focused on the lncRNA HOTAIR that
is regulated by genistein and investigated its functional role in PCa.
Results
Effect of Genistein Treatment on Proliferation, Apoptosis
and Cell Cycle in PCa Cells
To verify the tumor suppressive features of genistein, we
conducted function analysis. The MTS assay showed that the cell
proliferation was reduced by genistein treatment in both PC3 and
DU145 cells (Fig. 1A). Apoptosis assay demonstrated that genistein
significantly induced apoptosis of DU145 cells (Fig. 1B). However,
no significant effect of apoptosis was observed in PC3 cells. Cell
cycle assay demonstrated that treatment with genistein caused
G2/M phase cell cycle arrest in both PC3 and DU145 cells
(Fig. 1C).
Identification of Target Genes and Molecular Pathways
Regulated by Genistein in PCa
To identify genes and pathways targeted by genistein in PCa
cells, we performed gene expression profiling using genistein and
vehicle (control) treated PC3 and DU145 cells. The expression of
918 genes were significantly down-regulated in both PCa cell lines
(average log2 ratio,–0.5, Table S1). These genes were assigned
Kyoto Encyclopedia of Genes and Genomes (KEGG) annotations
using singular enrichment analysis of GeneCodis. Significantly
enriched pathways in KEGG were identified such as ‘Pathways in
cancer’, ‘Cell cycle’, ‘Regulation of actin cytoskeleton’ and ‘Jak-
STAT signaling pathway’ (P,0.05, Table S2). We focused on the
KEGG ‘Pathway in cancer’ and the genes in this pathway are
highlighted in the KEGG map (Fig. S1).
To determine gene expression in PCa clinical samples, we
performed expression analyses for all candidate target genes
involved in the ‘Pathways in cancer’ using microarray expression
data, which were approved by the Gene Expression Omnibus
(GEO). The expression levels of these genes were examined in
47 PCa and 47 normal samples, as shown in the heat map
diagram in Fig. S2. Genes up-regulated in PCa are shown in red,
down-regulated genes are shown in blue, while white bars indicate
genes that are expressed at similar levels in both. From this
analysis, several crucial gene targets were identified, including
histone deacetylase 1 (HDAC1), protein inhibitor of activated
STAT, 3 (PIAS3), tropomyosin 3 (TPM3), transcription factor 7-
like 2 (T-cell specific, HMG-box) (TCF7L2), aryl-hydrocarbon
receptor nuclear translocator 2 (ARNT2), CREB binding protein
(CREBBP), junction plakoglobin (JUP), and v-akt murine thymo-
ma viral oncogene homolog 2 (AKT2).
Identification of lncRNAs Regulated by Genistein in PCa
The SurePrint G3 Human GE 8660K microarray platform
also includes probes for lincRNAs. To identify the lncRNAs
regulated by genistein in PCa cells, we performed gene expression
profiling. Five lncRNAs were down-regulated in both PCa cell
lines (average log2 ratio,21.0, Table 1) with lncRNA HOTAIR
showing the largest effect. To determine relative expression levels
of HOTAIR in prostate cells, we performed quantitative real-time
Figure 1. Effect of genistein treatment on PCa cells (PC3 and DU145). (A) Genistein significantly inhibits cell viability. Cell viability was
analyzed by the MTS cell proliferation assay after 4 days treatment (25 mM). **, P,0.0001. *, P,0.01. Data are presented as the mean 6 SE. (B)
Apoptosis assay using flow cytometry. Representative quadrant figures of control and genistein (25 mM) treated cells in PC3 (left) and DU145 (right)
cells. P,0.05. (C) The typical figures of cell cycle analysis of control, or genistein (25 mM) treated cells are shown. The bar chart shown on the right of
each figures represents the percentage of the cells in G0/G1, S, or G2/M phase as indicated. *P,0.05.
doi:10.1371/journal.pone.0070372.g001
Table 1. Genistein down-regulated lncRNAs (less than 21.00-fold).
No. Entrez gene ID Symbol Gene name Log 2 ratio
PC3 DU145 Average
1 100124700 HOTAIR HOX transcript antisense RNA 21.92 21.23 21.58
2 100287628 LOC100287628 uncharacterized LOC100287628 21.59 21.35 21.47
3 145474 LOC145474 uncharacterized LOC145474 21.58 21.31 21.45
4 387097 C6orf147 chromosome 6 open reading frame 147 21.56 21.02 21.29
5 100507165 LOC100507165 uncharacterized LOC100507165 21.13 21.05 21.09
doi:10.1371/journal.pone.0070372.t001
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PCR using untreated PCa cell lines and compared them with
normal prostate epithelial cells (RWPE-1). We observed that
HOTAIR expression was significantly up-regulated in castration-
resistant PCa cell lines (PC3 and DU145) compared to RWPE-1
cells (PC3 3.35-fold, DU145 6.47-fold) (Fig. 2A). To confirm the
microarray data, we performed TaqMan quantitative real-time
PCR analysis and observed that HOTAIR expression was
significantly down-regulated with genistein treatment (Fig. 2B).
Thus we focused on HOTAIR because many investigators have
reported that HOTAIR has an oncogenic function in several other
cancers (breast, liver, pancreas, colorectal cancers and laryngeal
squamous cell carcinoma) [29–33].
Regulation of HOTAIR Expression in PCa Cell Lines by
miR-34a
Recently, it was reported that some miRNAs regulate the
expression of lncRNAs [35–37]. To search for potential miRNAs
that regulate HOTAIR, we used miRcode algorithm. In several
candidate miRNAs targeting HOTAIR, we focused on miR-34a
since our lab has been previously reported functions as a tumor
suppressor and is down-regulated in PCa tissues [38]. To
determine the relative expression levels of miR-34a in prostate
cells, we performed quantitative real-time PCR using PCa cell
lines (PC3 and DU145) and compared them with normal prostate
epithelial cells (RWPE-1). We observed that miR-34a expression
was significantly down-regulated in castration-resistant PCa cell
lines (PC3 and DU145) compared to RWPE-1 cells (PC3 0.22-
fold, DU145 0.14-fold) (Fig. 2C). To search for the effect of
genistein to miR-34a expression, we performed TaqMan quanti-
tative real-time PCR analysis and observed that miR-34a
expression was significantly up-regulated with genistein treatment
in DU145 cells (1.36-fold) (Fig. 2D).
In order to confirm the binding of miR-34a to HOTAIR, we
performed luciferase reporter assays. HOTAIR has one predicted
binding site for miR-34a (Fig. 3A) which we cloned into a
luciferase reporter assay vector. Luciferase reporter assays
demonstrated that miR-34a decreased the relative luciferase
activities of the wild type vector (Fig. 3B). Mutation of the
putative miR-34a binding sites also decreased the response to
miR-34a indicating that miR-34a binds directly to HOTAIR.
Quantitative real-time PCR analysis showed that the expression
levels of HOTAIR in PC3 and DU145 were repressed in the miR-
34a transfectants compared with the controls (Fig. 3C).
In vitro and in vivo Effect of HOTAIR on PCa Cell
Proliferation, Migration, and Invasion
To examine the functional role of HOTAIR, we performed
loss-of-function studies using si-RNA knockdown with PC3 and
DU145 cells. We initially confined that the expression of
HOTAIR was markedly repressed in si-RNA transfectants
compared to controls (Fig. 4A). Cell proliferation (Fig. 4B) and
wound healing assay (Fig. 4C) showed significant inhibition in si-
HOTAIR transfectants in both PC3 and DU145 cells compared
to the control transfectants. Invasion assay (Matrigel) also showed
that the number of invading cells was significantly decreased in si-
HOTAIR transfectants compared with their control counterparts
(Fig. 4D). To confirm the effect of HOTAIR on tumorigenicity
in vivo, HOTAIR siRNA and si-control-transfected DU145 cells
were subcutaneously injected into nude mice. We observed that
knock-down of HOTAIR expression inhibited DU145 cell tumor
Figure 2. Effect of genistein treatment and expression of HOTAIR and miR-34a in PCa cells. (A) Expression of HOTAIR in PCa cell lines
(LNCaP, PC3 and DU145) and normal prostate epithelial cells (RWPE-1). Real-time PCR showed that the expression levels of HOTAIR were up-regulated
in castration-resistant PCa cell lines (PC3 and DU145). Data are presented as mean 6 SE. *, P,0.05. (B) Expression levels of HOTAIR after treatment
with genistein (25 mM). HOTAIR expression decreased by 30–40% in genistein treated cells compared with controls. HOTAIR expression was
normalized to GAPDH. *, P,0.05. (C) Expression of miR-34a in PCa cell lines (PC3 and DU145) and normal prostate epithelial cells (RWPE-1). Real-time
PCR showed that the expression levels of miR-34a were down-regulated in castration-resistant PCa cell lines (PC3 and DU145). miR-34a expression
was normalized to RNU48. (D) Expression levels of miR-34a after treatment with genistein (25 mM) in DU145 cell. P,0.05.
doi:10.1371/journal.pone.0070372.g002
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formation in vivo (Fig. 4E). These results suggest that HOTAIR
plays an important role in PCa cell progression.
HOTAIR Influences Cellular Apoptosis and Cell Cycle in
PCa Cells
Apoptosis assay demonstrated that knock-down of HOTAIR
significantly induced apoptosis in both PC3 and DU145 cells
(Fig. 5A). Cell cycle assay showed that knock-down of HOTAIR
caused G2/M phase cell cycle arrest in PC3 cells (Fig. 5B) while
DU145 cells transfected had a significant increase in the S phase of
the cell cycle.
Discussion
Protein-coding genes comprise only a small part of the genome,
and the rest consists of ncRNAs, introns and/or other sequences to
which no function has yet been assigned [39]. NcRNAs (miRNAs
and lncRNAs) have been shown to play a critical role in regulation
of cellular processes such as cell growth and apoptosis in normal
and malignant cells. The roles of miRNAs in cancers have been
extensively investigated and recently, many lncRNAs have been
associated with the development and progression of cancer. The
expression of lncRNAs frequently changes during malignant
transformation and ncRNAs are emerging as key molecules in
human cancer, with the potential to serve as a novel markers and
therapeutic targets. However, to date the role of only a few
lncRNAs have been characterized in PCa. High-throughput
sequencing showed that prostate cancer–associated ncRNA
transcript 1 (PCAT-1) is a prostate-specific regulator of cell
proliferation in PCa and a target of PRC2 [40]. Prostate cancer
gene expression marker 1 (PCGEM1) polymorphisms may
contribute to PCa risk [41]. Expression of PlncRNA-1 is
significantly higher in PCa and this lncRNA regulates cell
proliferation and apoptosis through targeting androgen receptor
[42]. In this study, we focused on lncRNAs regulated by genistein
in PCa cells and identified HOTAIR in the expression profile of
these lincRNAs.
In this study, we found high expression of HOTAIR in
castration-resistant PCa cell lines. Our functional assays showed
that knockdown of HOTAIR decreased PCa cell proliferation
in vitro and in vivo and induced apoptosis. Therefore HOTAIR
may play a functional role in tumor cell growth in PCa. Increasing
Figure 3. miR-34a regulates HOTAIR expression. (A) Putative miR-34a binding and mutated sites in HOTAIR. (B) Luciferase reporter assays using
vectors encoding putative binding sites. PC3 and DU145 cells were transiently transfected with Pre-miR miRNA precursor or negative control,
followed by transient transfection with basic vector or wild-type reporter plasmids or mutated plasmids for 24 hours. Reporter activity was measured
by luciferase assay and normalized to the activity of Renilla luciferase. Data are presented as the mean 6 SE. *, P,0.05. (C) The expression level of
HOTAIR was determined by quantitative real-time PCR analyses after transfection with miR-34a mimics and negative control in PCa cell lines (PC3 and
DU145). HOTAIR expression was normalized to GAPDH. *, P,0.05.
doi:10.1371/journal.pone.0070372.g003
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Figure 4. siRNA knockdown of HOTAIR and effect on PCa cell viability. (A) HOTAIR expression levels in PCa cell lines (PC3 and DU145) were
determined by real-time PCR at 96 hours after transient transfection of siRNA. Gene expression was normalized to GAPDH. Data are presented as the
mean 6 SE. **, P,0.0001. *, P,0.0005. (B) Knockdown of HOTAIR significantly inhibits cell viability. Cell viability was analyzed by the MTS cell
proliferation assay 96 hours after transient transfection. (C) Knockdown of HOTAIR significantly inhibits cell migration. After transfection (48 hours), a
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evidence suggests that HOTAIR regulates key pathways in cancer
invasion and metastasis. HOTAIR increased breast cancer
invasiveness and metastasis by inducing positive regulators of
cancer metastasis (ABL2 SNAIL, LAMB3 and LAMC2) in a
manner dependent on PRC2 [29]. High HOTAIR expression is a
risk for recurrence after hepatectomy in hepatocellular carcinoma
and may regulate the MMP9 and VEGF genes [34]. Our
functional assays showed that knockdown of HOTAIR decreased
PCa cell migration and invasion. Our mRNA array data and
bioinformatic analysis also showed that genistein targets MMP9
and VEGF genes that are components of the KEGG ‘Pathway in
cancer’. These results indicate that HOTAIR may play an
important role in PCa progression.
As gene regulators, miRNAs bind to the 39UTR of mRNA and
can individually target a number of protein-coding genes.
However, it remains to be determined whether miRNAs can also
target lncRNAs. Recently, a few studies have described the
interactions between miRNAs and lncRNAs. miR-29 indirectly
regulates expression of tumor suppressor lncRNA, maternally
expressed 3 (MEG3) by acting on its methylation in hepatocellular
cancer [35]. miR-671 directs cleavage of an antisense transcript of
the cerebellar degeneration-related protein 1, 34 kDa (CDR1),
leading to a concomitant decrease in CDR1 [37]. In the present
study, we looked to see if miR-34a impacts lncRNA expression.
Our luciferase reporter assay and real-time PCR results showed
that miR-34a binds to the HOTAIR mRNA sequence and down-
regulates HOTAIR expression in PCa cell lines. Therefore this
study is the first to demonstrate that miR-34a directly targets
HOTAIR in both PC3 and DU145 PCa cells.
In conclusion, our results showed that genistein inhibits PCa cell
growth through down-regulation of oncogenic HOTAIR that is
targeted by tumor suppressor miR-34a. These findings enhance
our understanding of how genistein interacts with lncRNA in PCa
and indicates additional potential targets for PCa therapy.
Materials and Methods
Cell Culture
Human PCa cell lines, LNCaP, PC3 and DU145 and a non-
malignant epithelial prostate cell line, RWPE-1, were purchased
from The American Type Culture Collection (Manassas, VA,
USA). The PCa cell lines were cultured in RPMI 1640 medium
supplemented with 10% fetal bovine serum (FBS) in a humidified
atmosphere of 5% CO2 and 95% air at 37uC. RWPE-1 cell line
was cultured in keratinocyte growth medium supplemented with
5 ng/mL human recombinant epidermal growth factor and
0.05 mg/mL bovine pituitary extract (Invitrogen, Carlsbad, CA,
USA). Subconfluent cells (60%–70% confluent) were treated with
genistein (25 mmol/L; Sigma, St Louis, MO, USA) and cells
treated with vehicle (dimethylsulfoxide) served as control. Cell
media and genistein were changed every day and cells were grown
for 4 days.
RNA Extraction
Total RNA was extracted from PCa cell lines and a non-
malignant epithelial prostate cell line using a miRNeasy mini kit
(Qiagen, Valencia, CA, USA) according to the manufacturer’s
instructions.
Microarray
For microarray, total RNA was extracted from PC3 and DU145
cells treated with genistein using a miRNeasy Mini Kit. SurePrint
G3 Human GE 8660K Microarray (Agilent Technologies, Santa
Clara, CA, USA) was used for expression profiling of genistein
treated and control cells. The current microarray data were
approved by the GEO and were assigned GEO accession number
GSE47657.
Quantitative Real-time PCR
Extracted total RNA was reverse transcribed into single-
stranded cDNA using an iScript cDNA Synthesis Kit (Bio-Rad,
Hercules, CA, USA) and a TaqMan MicroRNA Reverse
Transcription Kit (Applied Biosystems, Foster City, CA, USA).
Quantitative real-time PCR analysis was performed with an
Applied Biosystems Prism7500 Fast Sequence Detection System
using TaqMan universal PCR master mix according to the
manufacturer’s protocol (Applied Biosystems). Levels of RNA
expression were determined using the 7500 Fast System SDS
software version 1.3.1 (Applied Biosystems). PCR parameters for
cycling were as follows: 95uC for 20 seconds, 40 cycles of PCR at
95uC for 3 seconds, and 60uC for 30 seconds. All reactions were
done in a 10-mL reaction volume in triplicate. The data were
analyzed with the delta-delta Ct method to calculate the fold-
change. TaqMan probes and primers for HOTAIR (assay ID:
Hs03296680_s1), GAPDH (assay ID: Hs02758991_g1), miR-34a
(assay ID: 000426), and RNU48 (Assay ID: 001006) were obtained
from Applied Biosystems. GAPDH and RNU48 were used as
internal controls.
Transfection
HOTAIR siRNA (SASI_Hs02_00380445 and SA-
SI_Hs02_00380446, Sigma) and negative control siRNA (D-
001810-10; Thermo Fisher Scientific, Waltham, MA, USA) were
used in loss-of-function experiments. Pre-miR miRNA precursor
and negative control (Applied Biosystems) were used in gain-of-
function experiments. PC3 and DU145 cells were transiently
transfected using Lipofectamine 2000 transfection reagent (Invi-
trogen), according to the manufacturer’s recommendations.
Cell Proliferation, Migration, and Invasion Assays
Cell proliferation was measured using a CellTiter 96 AQueous
One Solution Cell Proliferation Assay (MTS) kit (Promega,
Madison, WI, USA) performed according to the manufacturer’s
instructions. Cell proliferation was determined by absorbance
measurements at 490 nm using SpectraMAX 190 (Molecular
Devices Co., Sunnyvale, CA, USA). Cell migration activity was
evaluated by wound-healing assay. Cells were plated in six-well
dishes, and the cell monolayers were scraped using a P-20
micropipette tip. The width of the initial gap (0 h) and the residual
gap 24 hours after wounding were calculated from photomicro-
graphs. Cell invasion assay was carried out using modified Boyden
Chambers consisting of transwell-precoated Matrigel membrane
filter inserts with eight micron pores in 24-well tissue culture plates
(BD Biosciences, Bedford, MA, USA). Minimum essential medium
containing 10% FBS in the lower chamber served as the
chemoattractant, as described previously [43]. All experiments
were performed in triplicate.
wound was formed by scraping and measured after 24 hours. Representative images of wound healing assay are shown at 2006magnification. **,
P,0.0001. (D) Knockdown of HOTAIR significantly decreased cell invasion. Representative images of invasion assay are shown at 2006magnification.
**, P,0.0001. (E) Representative images of tumors in nude mice 5 weeks after subcutaneous injection of transfected HOTAIR siRNA DU145 cell lines
or control cell lines and time course of tumor growth.
doi:10.1371/journal.pone.0070372.g004
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In vivo Tumor Growth
All animal care was in accordance with the guidelines of the San
Francisco Veterans Affairs Medical Center and the study was
approved by the San Francisco VA IACUC (Protocol number: 11-
008-01). Animal users have completed training programs to
handle and work with mice through AALAS (American Associ-
ation for Laboratory Animal Science) prior to animal experiments.
For the subcutaneous xenograft mouse model, DU145 cells
(56106) that were transiently transfected with si-HOTAIR or si-
control were suspended in 100 mL RPMI 1640 medium and
subcutaneously injected into the left and right backside flanks of
female nude mice, respectively. (strain BALB/c nu/nu; Charles
River Laboratories, Inc., Wilmington, MA, USA, 5 weeks old). A
total of 4 nude mice were used and tumor growth was examined
over the course of 35 days. Tumor volume was calculated on the
basis of width (x) and length (y): x2y/2, where x,y.
Apoptosis and Cell Cycle Assays
Fluorescence-activated cell-sorting (FACS) analysis for apoptosis
was done 96 hours post-transfection, using a Annexin V-FITC/7-
AAD Kit (Beckman Coulter, Brea, CA, USA), according to the
manufacturer’s protocol. Cell cycle analysis was performed 96
hours after transfection. The cells were harvested, washed with
cold PBS and resuspended in the nuclear stain 49,6-diamidino-2-
phenylindole (Beckman Coulter). Stained cells were immediately
analyzed with a flow cytometer (Cell Lab Quanta SC; Beckman
Coulter).
Identification of Genistein Regulated Target Genes and
Bioinformatic Analysis
To search for genes that are regulated by genistein, we
performed microarray. To identify the biological processes or
pathways potentially regulated by genistein, we performed
GeneCodis analysis [44,45] using all of the candidate genes.
Then, to identify the networks among genistein and their target
genes, we analyzed and characterized those genes in GO
Biological Process and KEGG pathway categories. These data
were used to examine genistein-regulated molecular networks in
human cells. We performed gene expression analyses of all
candidate genes involved in each of the pathways using microarray
expression data, which were approved by the GEO and were
assigned GEO accession numbers (GSE29079). In the Affymetrix
Human Exon 1.0 ST Array (Affymetrix, Santa Clara, CA, USA)
datasets, we examined 47 PCa tissues and 47 normal prostate
tissues, all of which were collected from patients who had not been
exposed to neo-adjuvant radio-, cytotoxic- or endocrine therapy
before the operation. The data was normalized and analyzed with
the GeneSpring (Agilent Technologies). Statistical analyses were
conducted using the Mann Whitney U-test with cut-off P,0.05,
and the results are shown as a heat map diagram.
Plasmid Construction and Dual-luciferase Reporter
Assays
To search for miRNA targets of HOTAIR, we used the
miRcode algorithm (release 6.2, http://www.mircode.org/).
MiRcode provides human miRNA target predictions based on
the comprehensive GENCODE gene annotation [46], including
.10,000 long non-coding RNA genes. For luciferase reporter
assay, PmirGLO Dual-Luciferase miRNA Target Expression
Vector was used (Promega). The oligonucleotide sequences
(wild-type) used are shown in Table S3. We also constructed
mutated oligonucleotides for each of the wild-type oligonucleotides
(Table S3). In a total volume of 25 ml, 1 ml each of 100 mM
forward and reverse oligonucleotide, 2.5 ml of 10 X annealing
buffer (100 mM Tris–HCl, pH 7.5, 1 M NaCl and 10 mM
ethylenediaminetetraacetic acid) and 20.5 ml water were incubated
at 95uC for 3 min and then placed at 37uC for 15 min. The
oligonucleotides were ligated into the PmeI–XbaI site of
pmirGLO Dual-Luciferase miRNA Target Expression Vector.
For luciferase reporter assay, PCa cells were co-transfected with
Pre-miR miRNA precursor and pmirGLO Dual-Luciferase
miRNA Target Expression Vectors using Lipofectamine 2000
(Invitrogen) and X-tremeGENE HP DNA Transfection Reagent
(Roche Diagnosis, Basel, Switzerland, USA) according to the
manufacturer’s instructions. Luciferase reporter assay was per-
formed using the Dual-Luciferase Reporter Assay System
(Promega) 24 hours after transfection.
Statistical Analysis
The relationship between two variables and the numerical
values obtained by real-time RT-PCR were analyzed using the
nonparametric Mann-Whitney U test. All analyses were per-
formed using Expert StatView (version 4, SAS Institute Inc.). Data
are shown as mean values 6 standard error. In the comparison
among three variables, a nonadjusted statistical level of signifi-
cance of P,0.05 corresponds to a Bonferroni-adjusted level of
P,0.0167.
Supporting Information
Figure S1 Putative genistein regulated genes in ‘Path-
way in cancer’. The putative genistein regulated genes
(highlighted in red) as defined by Kyoto Encyclopedia of Genes
and Genomes (KEGG) pathway and determined through
GENECODIS analysis.
(TIF)
Figure S2 The heat map diagram of the ‘‘Pathways in
cancer’’. Analysis show prostate cancer tissues (n = 47) and
normal prostate samples (n = 47). Each square represents the
expression level of a given gene in an individual sample. Red
represents increased expression and blue represents decreased
expression relative to the normalised expression of the gene across
all samples.
(TIF)
Table S1 Genes downregulated by genistein.
(XLS)
Table S2 Pathways regulated by the targets of genistein
(KEGG annotation).
(XLS)
Table S3 Primer oligonucleotide sequences (wild-type
and mutated).
(XLS)
Figure 5. siRNA knockdown of HOTAIR and effect on PCa apoptosis and cell cycle. (A) Apoptosis assay using flow cytometry.
Representative quadrant figures of control and si-HOTAIR treated cells in PC3 (upper) and DU145 (lower) cells. **, P,0.005. *, P,0.05. (B) Typical
figures of cell cycle analysis of control, or si-HOTAIR treated cells are shown. The bar chart shown on the right of each figure represents the
percentage of the cells in G0/G1, S, or G2/M phase as indicated. **, P,0.001. *, P,0.005.
doi:10.1371/journal.pone.0070372.g005
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